期刊文献+

顽固性高血压的器械治疗:抑制交感神经活性

下载PDF
导出
摘要 世界范围内约34%的成人患有高血压[1],高血压已成为主要致死原因,占死亡原因的13%[2]。高血压的治疗主要包括生活方式的改善和药物治疗。然而,许多患者在接受治疗后血压仍未得到良好的控制。
作者 钱菊英 秦晴
出处 《上海医学》 CAS CSCD 北大核心 2014年第7期554-558,共5页 Shanghai Medical Journal
  • 相关文献

参考文献30

  • 1VERLOOP W L, VOSKUIL M, DOEVENDANS P A. Renal denervation: a new treatment option in resistant arterial hypertension[J]. Neth Heart J, 2013, 21(2): 95-98.
  • 2CASTRO TORRES Y, KATHOLI R E. Renal denervation for treating resistant hypertension: current evidence and future insights from a global perspective[J]. Int J Hyper- tens, 2013, 2013:513214.
  • 3CALHOUN D A, JONES D, TEXTOR S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American heart association professional education committee of the council for high blood pressure research[J]. Hypertension, 2008, 51(6): 1403-1419.
  • 4PERSELL S D. Prevalence of resistant hypertension in the United States, 2003-2008[J]. Hypertension, 2011, 57(6): 1076-1080.
  • 5HERING D, NARKIEWICZ K. Sympathetic nervous system and arterial hypertension: new perspectives, new data[J]. KardiolPol, 2013, 71(5): 441-446.
  • 6DIBONA G F. The sympathetic nervous system and hyper- tension= recent developments[J]. Hypertension, 2004, 43 (2) : 147-150.
  • 7LOHMEIER T E, HILDEBRANDT D A, WARREN S, et al. Recent insights into the interactions between the barore- flex and the kidneys in hypertension[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288(4): R828-R836.
  • 8SCHMIEDER R E, REDON J, GRASSI G, et al. ESH position paper: renal denervation--an interventional therapy of resistant hypertension[J].J Hypertens, 2012, 30 (5) 837-841.
  • 9Symplicity HTN-1 Investigators. Catheter-based renal sym- pathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months[J]. Hyperten- sion, 2011, 57(5): 911-917.
  • 10KRUM H, SOBOTKA P, MAHFOUD F, et al. Device- based antihypertensive therapy: therapeutic modulation of the autonomic nervous system[J]. Circulation, 2011, 123(2) : 209-215.

二级参考文献13

  • 1Calhoun DA, Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension, 2008, 51 : 1403-1419.
  • 2Krum H, Sobotka P, Mahfoud F, et al. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation, 2011,123 : 209-221.
  • 3Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof -of -principle cohort study. Lancet, 2009,373 : 1275-1281.
  • 4Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med, 2009, 361 : 932-934.
  • 5Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hyptersion: durability of blood pressure reduction out to 24 months. Hypertension, 2011,57:911-917.
  • 6Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension ( The Symplicity HTN-2 Trial) : a randomised controlled trial. Lancet, 2010,376 : 1903-1909.
  • 7Prochnau D, Lauten A, Busch M, et al. Catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system for drug resistant hypertension in a patient with end-stage renal disease. Int J Cardiol,2012,154 : e29-30.
  • 8Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol, 2011,58: 1176- 1182.
  • 9Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999, 130: 461-470.
  • 10Schlaich MP, Lambert E, Kaye DM, et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension, 2004, 43 : 169-175.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部